Trichomegaly of the eyelashes following treatment with cetuximab.
Bouché
O
O
Brixi-Benmansour
H
H
Bertin
A
A
Perceau
G
G
Lagarde
S
S
D000368:Aged; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use*; D000068818:Cetuximab; D005140:Eyelashes / Q000187:drug effects / Q000254:growth & development / Q000473:pathology; D005260:Female; D006201:Hair Diseases / Q000139:chemically induced*; D006801:Humans; D012004:Rectal Neoplasms / Q000188:drug therapy
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab